27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
- Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares surged 51 percent to $5.17. Cyclacel announced the presentation demonstrating therapeutic potential of CYC065 in lung cancer at the AACR 2017.
- Novocure Ltd (NASDAQ:NVCR) shares climbed 46 percent to $11.82 after the company disclosed that the two-year survival rate for GBM Patients increased from 30% to 43% for patients treated with Optune + temozolomide versus temozolomide alone at the AACR 2017.
- Steadymed Ltd (NASDAQ:STDY) shares surged 38.4 percent to $8.10. Cardiome's partner SteadyMed received a favorable ruling in USPTO Inter Partes Review in validity of U.S. Patent No. 8,497,393.
- Polarityte Inc (NASDAQ:COOL) shares rose 31 percent to $17.90.
- China Auto Logistics Inc (NASDAQ:CALI) shares surged 17 percent to $1.77.
- GEE Group Inc (NYSE:JOB) gained 15.5 percent to $5.65. GEE Group has acquired SNI Companies through merger.
- Professional Diversity Network Inc (NASDAQ:IPDN) climbed 12.1 percent to $10.75. Professional Diversity Network reported a FY16 loss of $1.98 per share on revenue of $26.23 million.
- AirMedia Group Inc (ADR) (NASDAQ:AMCN) shares jumped 10.6 percent to $3.04.
- Matinas BioPharma Holdings Inc (NYSE:MTNB) rose 8.3 percent to $3.00 in pre-market trading. Matinas BioPharma reported a FY16 loss of $0.21 per share.
- Cellect Biotechnology Ltd. (NASDAQ:APOP) rose 7.2 percent to $9.22 after the company reported an European patent grant.
- Eleven Biotherapeutics Inc (NASDAQ:EBIO) rose 6.8 percent to $2.35. Eleven Biotherapeutics presented new preclinical data supporting potential of the company's locally and systematically-administered drug candidates at the AACR 2017.
- Kite Pharma Inc (NASDAQ:KITE) climbed 5.6 percent to $82.86. Kite presented ongoing response rate in plenary session from its pivotal CAR-T trial of Axicabtagene Ciloleucel in patients with aggressive non-hodgkin lymphoma at AACR 2017.
- Syneron Medical Ltd. (NASDAQ:ELOS) shares gained 5.3 percent to $11.11. Syneron Candela agreed to be acquired by funds advised by Apax Partners for $11 per share in cash.
- Infinity Pharmaceuticals Inc. (NASDAQ:INFI) rose 5 percent to $3.39. Infinity Pharmaceuticals presented updated Phase 1 data for IPI-549 at the AACR 2017.
- Loxo Oncology Inc (NASDAQ:LOXO) gained 4.7 percent to $44.05. Morgan Stanley initiated coverage on Loxo Oncology with an Overweight rating.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!